Paradi Mirmirani
Dermatology · Vallejo, CANPI 1780758086
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $19,250 of the $31,325 with a category attached, or 61.5%. 4 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 53.1% of the total. 2025 is the largest year on record at $16,186, more than ten times the $1,190 reported in 2019. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 25 payments — averaging $1253.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$17K
- Pfizer$14K
- Eli Lilly$800
- Novartis$34
Across 736 payments — averaging $2641.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sun Pharmaceutical Industries Inc.$747K
- Incyte Corporation$463K
- Pfizer$360K
- Amgen$221K
- Eli Lilly$153K
What the payments were for
- Consulting fees$19,25061%
- Speaking & faculty fees$8,70028%
- Travel & lodging$2,5848%
- Food & beverage$7923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 11 | $16,636 |
| Pfizer | 12 | $13,856 |
| Eli Lilly | 1 | $800 |
| Novartis | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,325 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $63,634 |
| AdbryTralokinumab-Ldrm | 11 | $37,682 |
| Amjevita(Cf) AutoinjectorAdalimumab-Atto | 15 | $24,548 |
| Dutasteride | 141 | $4,940 |
| Tacrolimus | 38 | $3,754 |
| Acitretin | 37 | $3,692 |
| Fluocinolone Acetonide | 109 | $3,476 |
| Fluorouracil | 88 | $3,425 |
| Clobetasol Propionate | 128 | $3,118 |
| Doxycycline Monohydrate | 70 | $2,943 |
| Calcipotriene | 18 | $2,072 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 67 | $1,863 |
| Minoxidil | 162 | $1,860 |
| Hydroxychloroquine Sulfate | 36 | $1,575 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 17 | $1,435 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Vallejo
- Serena MrazVallejo$509K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.